CFB variants have been described in patients with aHUS (7–14, 31, 35, 36), in C3 glomerulopathy (15, 17) and in a few patients with immune-complex associated MPGN (16) but not all of them exhibit gain-of-function (12). This evidence concerns the gene CFB and primary membranoproliferative glomerulonephritis.